Market revenue in 2024 | USD 11.9 million |
Market revenue in 2030 | USD 16.7 million |
Growth rate | 5.8% (CAGR from 2024 to 2030) |
Largest segment | Instruments |
Fastest growing segment | Instruments |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments |
Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Koninklijke Philips NV, BD, BioMerieux SA, Bio-Rad Laboratories Inc, QuidelOrtho Corp, Siemens Healthineers AG ADR, Danaher Corp, Qiagen NV, Roche |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious respiratory disease diagnostics market will help companies and investors design strategic landscapes.
Instruments was the largest segment with a revenue share of 100% in 2024. Horizon Databook has segmented the Asia Pacific infectious respiratory disease diagnostics market based on instruments covering the revenue growth of each sub-segment from 2018 to 2030.
Increase in pro-health initiatives, adoption of better technologies, and rise in consumer awareness are driving market growth in this region. In addition, rising prevalence of infectious diseases, increasing demand for diagnostic products, and growing population base significantly contribute to market growth.
Asia Pacific markets such as China, Australia, Korea, and Taiwan already have a healthcare reimbursement system that provides an inclusive coverage for diagnostic tests. Increasing initiatives for scientific research, and positive economic growth coupled with high unmet needs are some primary growth drivers of this market.
Moreover, improving healthcare regulatory scenario in the high growth countries is expected to attract international players to invest and capitalize on the available opportunities. Positive changes, such as healthcare benefits by government, increased awareness amongst the population, and an urge to avail high-end medical treatment are also expected to drive regional market growth.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific infectious respiratory disease diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific infectious respiratory disease diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account